Expression of the HTLV-III envelope gene by a recombinant vaccinia virus - PubMed (original) (raw)
. 1986 Apr;320(6062):535-7.
doi: 10.1038/320535a0.
- PMID: 3008001
- DOI: 10.1038/320535a0
Expression of the HTLV-III envelope gene by a recombinant vaccinia virus
S Chakrabarti et al. Nature. 1986 Apr.
Abstract
The discovery that the aetiological agent of acquired immune deficiency syndrome (AIDS) is a retrovirus, referred to as human T-lymphotropic virus type III (HTLV-III) or lymphadenopathy-associated virus (LAV) (for review see ref. 1), has raised the possibility of developing a vaccine. In this regard, the envelope (env) proteins of murine retroviruses can induce protective immunity in mice. The HTLV-III env gene specifies a primary polypeptide of approximately 860 amino acids that is glycosylated to form a precursor of relative molecular mass (Mr) 160,000 (gp160), which gives rise to mature membrane-associated proteins of Mr 120,000 (gp120) and 41,000 (gp41). The HTLV-III env gene has been expressed in Escherichia coli and by simian virus 40 (SV40) vectors but formation of the authentic proteins has not been demonstrated. Here, we describe the expression of the complete env gene by a vaccinia virus vector. Evidence is presented that synthesis, glycosylation, processing and membrane transport of the env polypeptide occurred without other HTLV-III gene functions; the env protein was recognized by sera from unrelated AIDs patients; and a single vaccination with the infectious recombinant vaccinia virus induced antibodies to gp120 in mice.
Similar articles
- Expression of AIDS virus envelope gene in recombinant vaccinia viruses.
Hu SL, Kosowski SG, Dalrymple JM. Hu SL, et al. Nature. 1986 Apr 10-16;320(6062):537-40. doi: 10.1038/320537a0. Nature. 1986. PMID: 3008002 - Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.
Veronese FD, DeVico AL, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG. Veronese FD, et al. Science. 1985 Sep 27;229(4720):1402-5. doi: 10.1126/science.2994223. Science. 1985. PMID: 2994223 - Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.
Shida H, Tochikura T, Sato T, Konno T, Hirayoshi K, Seki M, Ito Y, Hatanaka M, Hinuma Y, Sugimoto M, et al. Shida H, et al. EMBO J. 1987 Nov;6(11):3379-84. doi: 10.1002/j.1460-2075.1987.tb02660.x. EMBO J. 1987. PMID: 2828027 Free PMC article. - Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M, McLane MF, Kanki P, Allan J, Kitchen L, Lee TH. Essex M, et al. Cancer Res. 1985 Sep;45(9 Suppl):4534s-4538s. Cancer Res. 1985. PMID: 2990682 Review. - Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
Fischinger PJ, Robey WG, Koprowski H, Gallo RC, Bolognesi DP. Fischinger PJ, et al. Cancer Res. 1985 Sep;45(9 Suppl):4694s-4699s. Cancer Res. 1985. PMID: 2410115 Review.
Cited by
- The live vector approach-viruses.
Mackett M. Mackett M. World J Microbiol Biotechnol. 1991 Mar;7(2):137-49. doi: 10.1007/BF00328983. World J Microbiol Biotechnol. 1991. PMID: 24424925 - HIV-1 neutralizing antibodies: understanding nature's pathways.
Mascola JR, Haynes BF. Mascola JR, et al. Immunol Rev. 2013 Jul;254(1):225-44. doi: 10.1111/imr.12075. Immunol Rev. 2013. PMID: 23772623 Free PMC article. Review. - Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation.
Kassa A, Finzi A, Pancera M, Courter JR, Smith AB 3rd, Sodroski J. Kassa A, et al. J Virol. 2009 May;83(9):4476-88. doi: 10.1128/JVI.02110-08. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211747 Free PMC article. - Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
Wang BZ, Liu W, Kang SM, Alam M, Huang C, Ye L, Sun Y, Li Y, Kothe DL, Pushko P, Dokland T, Haynes BF, Smith G, Hahn BH, Compans RW. Wang BZ, et al. J Virol. 2007 Oct;81(20):10869-78. doi: 10.1128/JVI.00542-07. Epub 2007 Aug 1. J Virol. 2007. PMID: 17670815 Free PMC article. - The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.
Castagna A, Biswas P, Beretta A, Lazzarin A. Castagna A, et al. Drugs. 2005;65(7):879-904. doi: 10.2165/00003495-200565070-00001. Drugs. 2005. PMID: 15892586
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources